A media briefing from experts from the Infectious Diseases Society of America to discuss the recent authorization of COVID-19 vaccines for children under age 5.
- Overview of pediatric clinical trials
- Value of vaccination during this phase of the pandemic
- Recommendations for parents and caregivers
- Questions from media
FEATURED:
C. Buddy Creech, MD, MPH, FPIDS—Vanderbilt University School of Medicine
Member, Infectious Diseases Society of America
President, Pediatric Infectious Diseases Society
Director, Vanderbilt Vaccine Research Program
Edie Carell Johnson Chair and Professor, Department of Pediatrics, Division of Pediatric Infectious Diseases
Jason G. Newland MD, MEd, FPIDS—Washington University School of Medicine in St. Louis
Member, Infectious Diseases Society of America
Professor of Pediatrics, Pediatric Infectious Diseases
Vice Chair of Community Health and Strategic Planning
Chris Busky, CAE (Moderator)
Chief Executive Officer—Infectious Diseases Society of America
